Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(337)
•••
Comment by jayjay2020on Mar 26, 2019 12:02pm
103 Views
Post# 29536963

RE:RE:RE:Key points from Irwin's Bloomberg interview

RE:RE:RE:Key points from Irwin's Bloomberg interview
skyplt wrote: Alloparc:  The key take away for me was that 1 Billion remark when it came to expected revenue.  Funny...CRON brings in 5M and it is a collective "meh".  APHA suggests a billion on the horizon and it is also a collective "meh".  Sadly, we are very much in a 'show me the money' situation with Aphria as there is no trust.  That lack of trust is well earned thanks to (quote Harry Potter) someone who's name we will not mention.  Hopefully Q3 will start to convince some that 1 billion is doable.

Alloparc wrote:
Honestly, not sure how I feel about this interview.

 
The $1B revenue remark was clearly a lead statement into the current earnings report.  What he is saying is watch out .  APHA earnings will be good and will pass $1B very quickly. 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities